Polares Medical is developing MRace, a transcatheter system for replacing the posterior leaflet of the mitral valve. The Lausanne company has closed a USD 50 million Series C to fund clinical studies in the United States, Europe and Australia.
- Announced on
- Round
- Series C and later
- Amount
- USD 50 M
- Location
- Lausanne, canton of Vaud
- Sector
- Health & medtech
Investors
- DC Global Ventures
- Lumination Partners
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic